Sanofi, GSK Delay COVID Vaccine On Low Response In Older Adults
December 11, 2020 at 08:25 AM EST
Sanofi and GlaxoSmithKline announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults.
